National Comprehensive Cancer Network

NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines® & Clinical Resources

NCCN 3rd Annual Congress Hematologic Malignancies

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Congress Agenda

Satellite Symposia

Intended Audience

Accommodations

Registration Information

Accreditation

Commercial Support

Exhibiting

Refer a Friend


Go back to previous page

 

 

     
 

NCCN 3rd Annual Congress:
Hematologic Malignancies™
Agenda


Friday, September 5, 2008

Registration, Breakfast, and Exhibits
7:30 - 8:45 AM

Welcome
8:45 – 8:55 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Lymphomas

Treatment of Acute Lymphocytic Leukemia
8:55 – 9:55 AM
L. Andres Sirulnik, MD, PhD
Dana-Farber/Brigham and Women`s Cancer Center

Treatment of Cutaneous T-cell Lymphoma
10:00 – 10:45 AM
Steven M. Horwitz, MD
Memorial Sloan-Kettering Cancer Center

Break and Exhibits
10:45 – 11:05 AM

Radioimmunotherapy in Lymphomas
11:05 – 11:50 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Lunch and Exhibits
11:50 AM – 12:50 PM

The Evolving Role of Multi-Modality Therapy in Hodgkin’s Lymphoma
12:50 – 1:35 PM
Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Role of PET in the Diagnosis and Management of Lymphomas
1:40 – 2:25 PM
Donald A. Podoloff, MD
The University of Texas MD Anderson Cancer Center

Break and Exhibits
2:25 – 2:45 PM

Chronic Myelogenous Leukemia

Update on Frontline Therapy of CML with Imatinib and Results with Second Generation Tyrosine Kinase Inhibitors
2:45 – 3:30 PM
Susan O’Brien, MD
The University of Texas MD Anderson Cancer Center

Combating Progressive Disease by Monitoring and Early Detection: War and PCR
3:35 – 4:20 PM
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Closing Remarks
4:25 – 4:30 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Reception and Exhibits
4:30 – 6:15 PM


Saturday, September 6, 2008
8:00 AM – 12:45 PM

Registration & Breakfast
7:30 – 8:00 AM

Welcome
8:00 – 8:05 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Supportive Care

Anemia and Myelodysplastic Syndromes
8:05 – 8:50 AM
Peter L. Greenberg, MD
Stanford Comprehensive Cancer Center

Panel Discussion – ESAs: Risk Benefit Analysis
8:55 – 9:55 AM
Pamela S. Becker, MD, PhD
University of Washington Medical Center

Charles L. Bennett, MD, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Eric H. Kraut, MD
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University

Issues in Advanced Directives: Changing Goals and Realities with Advancing Disease
10:00 – 10:45 AM
Cameron Muir, MD
Capital Hospice

Break  
10:45 – 11:05 AM

Multiple Myeloma

Supportive Care in Multiple Myeloma
11:05 – 11:50 AM
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women’s Cancer Center

Sequencing of Therapies for Multiple Myeloma
11:55 AM – 12:40 PM
Seema Singhal, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Closing Remarks
12:40 – 12:45 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

View information on the NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™.

Last update 06/23/2008. Subject to change.